Overview
- 8 inspections across 8 sites are on record.
- 0 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2011-05-05.
At a glance
Inspections
8
Sites
8
Observations
0
Career since
Jun 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| SmithKline Beecham Pharma GmbH & co. KG (dba GlaxoSmithKline Biologicals) | 5 May 2011 | On file | |
| PCI San Diego, Inc. | 1 Apr 2011 | On file | |
| CAF-DAF scrl | 15 Sep 2010 | On file | |
| Baxalta US Inc. | 15 May 2009 | On file | |
| GSK Vaccines S.r.l. | 13 Feb 2009 | On file |
Sites inspected
SmithKline Beecham Pharma GmbH & co. KG (dba GlaxoSmithKline Biologicals)Dresden, Germany1 insp.
PCI San Diego, Inc.San Diego, United States1 insp.
CAF-DAF scrlNeder-over- Heembeek, Belgium1 insp.
Baxalta US Inc.Thousand Oaks, United States1 insp.
GSK Vaccines S.r.l.Siena, Italy1 insp.
Co-investigators
Investigators who share inspections with this person.
Grace Deneke1 shared
Qiao Y Bobo1 shared
Anthony F Lorenzo1 shared
Joyce A Rockwell1 shared
Joseph George1 shared
Full investigator report
Get the verbatim findings behind Rebecca K Olin's inspection record
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site